Abstract
Background:
Ashanti pepper (Piper guineense Schumach et Thonn) seed is well known in folkloric medicine in the management of type 2 diabetes (T2DM) with little or no scientific documentation for its action. This study investigated the effect of Ashanti pepper seed on some enzymes relevant to carbohydrate hydrolysis, blood regulation and the cholinergic system, as well as the blood glucose level, lipid profile, antioxidant parameters, and hepatic and renal function markers in T2DM rats.
Methods:
T2DM was induced by feeding rats with high-fat diet (HFD) for 14 days followed by a single intraperitoneal dose of 35 mg/kg body weight of streptozotocin (STZ). Three days after STZ induction, diabetic rats were placed on a dietary regimen containing 2%–4% Ashanti pepper.
Results:
Reduced blood glucose level with decreased α-amylase, α-glucosidase and angiotensin I converting enzyme (ACE) activities were observed in Ashanti pepper seed and acarbose-treated rat groups when compared to that of the diabetic control rat group. Furthermore, the results revealed that inclusion of 2%–4% Ashanti pepper seed in diabetic rat fed group diets may ameliorate the lipid profile, antioxidant status, and hepatic and renal function in T2DM rats as much as in the acarbose-treated groups. In addition, a chromatographic profile of the seed revealed the presence of quercitrin (116.51 mg/g), capsaicin (113.94 mg/g), dihydrocapsaicin (88.29 mg/g) and isoquercitrin (74.89 mg/g).
Conclusions:
The results from this study clearly suggest that Ashanti pepper could serve as a promising source of phenolic compounds with great alternative therapeutic potentials in the management of T2DM.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was funded by the Education Trust Fund Academic Staff Training and Development (AST & D) Intervention (Ref: FUTA/VCPU/ETF/155).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Dahiru T, Jibo A, Hassan AA, Mande AT. Prevalence of diabetes in a semi-urban community in northern Nigeria. Nig J Med 2008;17:414–6.10.4314/njm.v17i4.37423Search in Google Scholar
2. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet 2010;375:2254–66.10.1016/S0140-6736(10)60550-8Search in Google Scholar
3. International Diabetes Federation. IDF diabetes atlas, 6th ed. Brussels: International Diabetes Federation, 2013.Search in Google Scholar
4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization (WHO/NCD/NCS/99.2), 1999.Search in Google Scholar
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53.10.2337/diacare.27.10.2569-aSearch in Google Scholar
6. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J 2012;27:269–73.10.5001/omj.2012.68Search in Google Scholar
7. Bajaj M, DeFronzo RA. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 2003;10:311–23.10.1016/S1071-3581(03)00520-8Search in Google Scholar
8. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997;5:117–9.Search in Google Scholar
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(Suppl 1):S62–7.10.2337/dc09-S062Search in Google Scholar PubMed PubMed Central
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(Suppl 1):S64–71.10.2337/dc12-s064Search in Google Scholar PubMed PubMed Central
11. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000;49:1390–4.10.1053/meta.2000.17721Search in Google Scholar PubMed
12. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type-2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313–20.10.1016/j.phrs.2005.05.004Search in Google Scholar PubMed
13. Abou-Seif MA, Youssef A. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004;346:161–70.10.1016/j.cccn.2004.03.030Search in Google Scholar PubMed
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–82.10.1038/414813aSearch in Google Scholar
15. Karbach S, Jansen T, Horke S, Heeren T, Scholz A, Coldewey M, et al. Hyperglycemia and oxidative stress in cultured endothelial cells – a comparison of primary endothelial cells with an immortalized endothelial cell line. J Diabetes Complicat 2012;26:155–62.10.1016/j.jdiacomp.2012.03.011Search in Google Scholar
16. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661–6.10.1001/archneur.61.5.661Search in Google Scholar
17. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy. Phys Ther 2008;88:1322–35.10.2522/ptj.20080008Search in Google Scholar
18. Kim JS, Kwon CS, Son KH. Inhibition of α-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem 2000;64:2458–61.10.1271/bbb.64.2458Search in Google Scholar
19. Kwon YI, Apostolidis E, Kim YC, Shetty K. Health benefits of traditional corn, beans, and pumpkin: In vitro studies for hyperglycemia and hypertension management. J Med Food 2007;10:266–75.10.1089/jmf.2006.234Search in Google Scholar
20. Adefegha SA, Oboh G. In vitro inhibition activity of polyphenol-rich extracts from Syzygium aromaticum (L.) Merr. & Perry (Clove) buds against carbohydrate hydrolyzing enzymes linked to type-2 diabetes and Fe2 + -induced lipid peroxidation in rat pancreas. Asian Pac J Trop Biomed 2012;2:774–81.10.1016/S2221-1691(12)60228-7Search in Google Scholar
21. McDougall GJ, Shpiro F, Dobson P, Smith P, Blake A, Stewart D. Different polyphenolic components of soft fruits inhibit α-amylase and α-glucosidase. J Agric Food Chem 2005;53:2760–6.10.1021/jf0489926Search in Google Scholar PubMed
22. Volpe M, Savoia C, De Paolis P. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J Am Soc Nephrol 2002;13(Suppl 3):S173–8.10.1097/01.ASN.0000032549.36050.78Search in Google Scholar PubMed
23. Ma TK, Kam KK, Yan BP, Lam YY. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 2010;160:1273–92.10.1111/j.1476-5381.2010.00750.xSearch in Google Scholar PubMed PubMed Central
24. Deedwania PC. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Cardiol Clin 2005;23:139–52.10.1016/j.ccl.2004.06.006Search in Google Scholar
25. Mushtaq N, Schmatz R, Pereira LB, Ahmad M, Stefanello N, Vieira JM, et al. Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats. Cell Biochem Funct 2014;32:287–93.10.1002/cbf.3014Search in Google Scholar
26. Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol 2011;71:365–76.10.1111/j.1365-2125.2010.03830.xSearch in Google Scholar
27. Kroner Z. The relationship between Alzheimer’s disease and diabetes: type 3 diabetes? Altern Med Rev 2009;14:373–9.Search in Google Scholar
28. Melo JB, Agostinho P, Oliveira CR. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 2003;45:117–27.10.1016/S0168-0102(02)00201-8Search in Google Scholar
29. Ezuruike UF, Prieto JM. The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol 2014;155:857–924.10.1016/j.jep.2014.05.055Search in Google Scholar
30. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007;40:163–73.10.3164/jcbn.40.163Search in Google Scholar
31. Adefegha SA, Oboh G. Enhancement of total phenolics and antioxidant properties of some tropical green leafy vegetables by steam cooking. J Food Process Preserv 2011;35:615–22.10.1111/j.1745-4549.2010.00509.xSearch in Google Scholar
32. Kim M, Kim E, Kwak HS, Jeong Y. The ingredients in Saengshik, a formulated health food, inhibited the activity of α-amylase and α-glucosidase as anti-diabetic function. Nutr Res Pract 2014;8:602–6.10.4162/nrp.2014.8.5.602Search in Google Scholar
33. Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012;2:320–30.10.1016/S2221-1691(12)60032-XSearch in Google Scholar
34. Abila B, Richens A, Davies JA. Anticonvulsant effects of extracts of the West African black pepper, Piper guineense. J Ethnopharmacol 1993;39:113–7.10.1016/0378-8741(93)90026-2Search in Google Scholar
35. Adewoyin FB, Odaibo AB, Adewunmi CO. Mosquito repellent activity of Piper guineense and Xylopia aethiopica fruits oils on Aedes Aegypti. Afr J Tradit Complement Altern Med 2006;3:79–83.10.4314/ajtcam.v3i2.31160Search in Google Scholar
36. Olonisakin A, Oladimeji MO, Lajide L. Chemical composition and antibacterial activity of steam distilled oil of Ashanti pepper (Piper guineense) fruits (Berries). Electron J Environ Agric Food Chem 2006;5:1531–5.Search in Google Scholar
37. Oyedeji OA, Adeniyi BA, Ajayi O, König WA. Essential oil composition of Piper guineense and its antimicrobial activity. Another chemotype from Nigeria. Phytother Res 2005;19:362–4.10.1002/ptr.1679Search in Google Scholar
38. Adefegha SA, Oboh G. Phytochemistry and mode of action of some tropical spices in the management of type-2 diabetes and hypertension. Afr J Pharm Pharmacol 2013;7:332–46.10.5897/AJPPX12.014Search in Google Scholar
39. Adefegha SA, Oboh G. Inhibition of key enzymes linked to type-2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices. Pharm Biol 2012;50:857–65.10.3109/13880209.2011.641022Search in Google Scholar
40. Adefegha SA, Oboh G. Effect of diets supplemented with Ethiopian pepper [Xylopia aethiopica (Dun.) A. Rich (Annonaceae)] and Ashanti pepper [Piper guineense Schumach. et Thonn (Piperaceae)] on some biochemical parameters in normal rats. Asian Pac J Trop Biomed 2012;2(Suppl):S558–66.10.1016/S2221-1691(12)60274-3Search in Google Scholar
41. Adefegha SA, Oboh G, Adefegha OM, Boligon AA, Athayde ML. Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocin-induced diabetes rat model. J Sci Food Agric 2014;94:2726–37.10.1002/jsfa.6617Search in Google Scholar
42. Worthington V. Alpha amylase. In: Worthington K, Worthington V, editors. Worthington enzyme manual. NJ: Worthington Biochemical Corp Freehold, 1993:36–41.Search in Google Scholar
43. Oboh G, Akinyemi JA, Ademiluyi AO, Adefegha AS. Inhibitory effect of aqueous extract of two varieties of ginger on key enzymes linked with type-2 diabetes. J Food Nutr Res 2010;49:14–20.Search in Google Scholar
44. Apostolidis E, Kwon YI, Shetty K. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov Food Sci Emerg Technol 2007;4:46–54.10.1016/j.ifset.2006.06.001Search in Google Scholar
45. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the Angiotensin I converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637–48.10.1016/0006-2952(71)90292-9Search in Google Scholar
46. Ellman GL, Lourtney DK, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.10.1016/0006-2952(61)90145-9Search in Google Scholar
47. Gutierres JM, Carvalho FB, Schetinger MR, Agostinho P, Marisco PC, Vieira JM, et al. Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia in rats. Int J Dev Neurosci 2014;33:88–97.10.1016/j.ijdevneu.2013.12.006Search in Google Scholar PubMed
48. Lawerence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat’s liver. Biochem Biophys Res Commun 1961;71:952–8.10.1016/0006-291X(76)90747-6Search in Google Scholar
49. Jacques-Silva MC, Nogueira CW, Broch LC, Flores EM, Rocha JB. Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice. Pharmacol Toxicol 2001;88:119–25.10.1034/j.1600-0773.2001.d01-92.xSearch in Google Scholar
50. Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferases: the first enzymatic step in mercaptoric acid formation. J Biol Chem 1974;249:7130–9.10.1016/S0021-9258(19)42083-8Search in Google Scholar
51. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.10.1016/0003-2697(79)90738-3Search in Google Scholar
52. Adam-Vizi V, Seregi M. Receptor dependent stimulatory effect of noradrenaline on Na + /K + ATPase in rat brain homogenate: role of lipid peroxidation. Biochem Pharmacol 1982;31:2231–6.10.1016/0006-2952(82)90106-XSearch in Google Scholar
53. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4 bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974;11:151–69.10.1159/000136485Search in Google Scholar
54. Misra HP, Fridovich I. The generation of superoxide radical during the antioxidant of hemoglobin. J Biol Chem 1972;247:6960–2.10.1016/S0021-9258(19)44679-6Search in Google Scholar
55. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265–75.10.1016/S0021-9258(19)52451-6Search in Google Scholar
56. Asru KS. Colorimetric assay of catalase. Anal Biochem 1972;47:389–94.10.1016/0003-2697(72)90132-7Search in Google Scholar
57. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci 2014;11:1185–200.10.7150/ijms.10001Search in Google Scholar PubMed PubMed Central
58. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2011;8:228–36.10.1038/nrendo.2011.183Search in Google Scholar PubMed
59. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007;2:219–36.Search in Google Scholar
60. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 2010;4:118–26.10.4103/0973-7847.70902Search in Google Scholar PubMed PubMed Central
61. Frode TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 2008;115:173–83.10.1016/j.jep.2007.10.038Search in Google Scholar PubMed
62. Manaer T, Yu L, Zhang Y, Xiao XJ, Nabi XH. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin. J Ethnopharmacol 2015;169:269–74.10.1016/j.jep.2015.04.032Search in Google Scholar PubMed
63. Banu S, Jabir NR, Manjunath NC, Khan MS, Ashraf GM, Kamal MA, et al. Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients. Saudi J Biol Sci 2015;22:32–6.10.1016/j.sjbs.2014.04.005Search in Google Scholar PubMed PubMed Central
64. Shinde J, Taldone T, Barletta M, Kunaparaju N, Hu B, Kumar S, et al. α-Glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. Carbohydr Res 2008:343;1278–81.10.1016/j.carres.2008.03.003Search in Google Scholar PubMed
65. Irudayaraj SS, Sunil C, Duraipandiyan V, Ignacimuthu S. Antidiabetic and antioxidant activities of Toddalia asiatica (L.) Lam. leaves in streptozotocin induced diabetic rats. J Ethnopharmacol 2012;143:515–23.10.1016/j.jep.2012.07.006Search in Google Scholar PubMed
66. Ma Y, Zhao D, Zhou A, Zhang Y, Du Z, Zhang K. α-Glucosidase inhibition and antihyperglycemic activity of phenolics from the flowers of Edgeworthia gardneri. J Agric Food Chem 2015;63:8162–9.10.1021/acs.jafc.5b03081Search in Google Scholar PubMed
67. Musabayane CT. The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. Cardiovasc J Afr 2012;23:462–8.10.5830/CVJA-2012-025Search in Google Scholar PubMed PubMed Central
68. Kukongviriyapan U, Kukongviriyapan V, Pannangpetch P, Donpunha W, Sripui J, Sae-Eaw A, et al. Mamao Pomace extract alleviates hypertension and oxidative stress in nitric oxide deficient rats. Nutrients 2015;7:6179–94.10.3390/nu7085275Search in Google Scholar PubMed PubMed Central
69. Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Corrêa M, et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009;610:42–8.10.1016/j.ejphar.2009.03.032Search in Google Scholar
70. Maiti R, Misra DS, Ghosh D. Hypoglycemic and hypolipidemic effect of seed hydromethanolic extract of tamarindus indica L. on streptozotocin-induced diabetes mellitus in rat. Am J Phytomed Clin Ther 2014;2:1416–29.Search in Google Scholar
71. Veerapur VP, Prabhakar KR, Thippeswamy BS. Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats: a mechanistic study. Food Chem 2012;132: 186–93.10.1016/j.foodchem.2011.10.052Search in Google Scholar
72. Afzal M, Khan NA, Ghufran A, Iqbal A, Inamuddin M. Diuretic and nephroprotective effect of Jawarish Zarooni Q’V, Sada – a polyherbal unani formulation. J Ethnopharmacol 2004;91:219–23.10.1016/j.jep.2003.12.029Search in Google Scholar
73. Mittler R. Oxidative stress, antioxidants and stress tolerance. Trends Plant Sci 2002;7:405–10.10.1016/S1360-1385(02)02312-9Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
